Latest news
CF PharmTech completes HK$13.82 H-share placing to broaden investor base - TipRanksTipRanks · Thu, 06 Aug 2026 19:13:31 GMTSelected Hong Kong Stock Exchange Announcements | BioInnovate reported a year-on-year increase of approximately 400% in interim profit; China Overseas Land & Investment recorded sales of nearly RMB 150 billion in the first seven months. - MoomooMoomoo · Thu, 06 Aug 2026 12:48:20 GMTCF PharmTech (2652 HK) Placement: Raising Fund to Feed R&D Amid Unutilized IPO Proceeds - SmartkarmaSmartkarma · Sun, 02 Aug 2026 07:00:00 GMTCF PHARMTECH - TO PLACE 21.7 MLN NEW H SHARES AT HK$13.82 PER SHARE - MoomooMoomoo · Thu, 30 Jul 2026 22:51:00 GMT